Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Next generation automation lab achieves huge productivity gains

Next generation automation lab achieves huge productivity gains

Study could lead to blood-based diagnostic test for schizophrenia

Study could lead to blood-based diagnostic test for schizophrenia

Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development

Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development

Researchers identify an unexpected effect for already characterized active substances

Researchers identify an unexpected effect for already characterized active substances

ATN framework can be extended to detect frontotemporal degeneration

ATN framework can be extended to detect frontotemporal degeneration

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

New live cell models lay the groundwork for studies into mitochondrial diseases

New live cell models lay the groundwork for studies into mitochondrial diseases

UH researchers report new gut–liver drug recycling process

UH researchers report new gut–liver drug recycling process

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

New approach that uses machine learning could transform drug development

New approach that uses machine learning could transform drug development

Untargeted metabolomics profiling can improve diagnosis of metabolic disorders in newborns

Untargeted metabolomics profiling can improve diagnosis of metabolic disorders in newborns

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

Novel technique allows to individually select droplets for contact in droplet-array sandwiching

Novel technique allows to individually select droplets for contact in droplet-array sandwiching

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

Laboratory manufactured protein spikes mimic key features of SARS-CoV-2 virus

Laboratory manufactured protein spikes mimic key features of SARS-CoV-2 virus

Antibiotic clofoctol shows potential against SARS-CoV-2

Antibiotic clofoctol shows potential against SARS-CoV-2

SwabSeq platform offers a potential solution for massive COVID-19 testing

SwabSeq platform offers a potential solution for massive COVID-19 testing

FairJourney Biologics introduces “THE ANTIBODY SERIES” conference

FairJourney Biologics introduces “THE ANTIBODY SERIES” conference

New article focuses on drug discovery targeting SARS-CoV-2

New article focuses on drug discovery targeting SARS-CoV-2

Breakthrough method for tracking mRNA molecules with fluorescence

Breakthrough method for tracking mRNA molecules with fluorescence